NEEGX
Price
$67.14
Change
-$0.56 (-0.83%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

NEEGX vs RPTIX

Header iconNEEGX vs RPTIX Comparison
Open Charts NEEGX vs RPTIXBanner chart's image
Needham Growth Retail
Price$67.14
Change-$0.56 (-0.83%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NEEGX vs RPTIX Comparison Chart
Loading...
VS
NEEGX vs. RPTIX commentary
Sep 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEEGX is a Sell and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.2B vs. NEEGX (229M). RPTIX pays higher dividends than NEEGX: RPTIX (0.18) vs NEEGX (0.00). NEEGX was incepted earlier than RPTIX: NEEGX (29 years) vs RPTIX (9 years). RPTIX is a more actively managed with annual turnover of: 21.70 vs. NEEGX (9.00). NEEGX has a lower initial minimum investment than RPTIX: NEEGX (2000) vs RPTIX (500000). NEEGX annual gain was more profitable for investors over the last year : 39.70 vs. RPTIX (14.81). NEEGX return over 5 years is better than : 56.43 vs. RPTIX (15.09).
NEEGXRPTIXNEEGX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years9 years-
Gain YTD21.3459.127234%
Front LoadN/AN/A-
Min. Initial Investment20005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets229M31.2B1%
Annual Yield % from dividends0.000.18-
Returns for 1 year39.7014.81268%
Returns for 3 years-0.27-13.572%
Returns for 5 years56.4315.09374%
Returns for 10 years46.27N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp